CD8A and hepatocellular carcinoma: This suggests that there is a difference in the activation of anti-AFP CD4 vs CD8 T cells in HCC patients, with a CD4 T-cell response expanding in early stages of disease, which is usually associated with low concentrations of serum AFP, and with exhaustion of this response in later stages of disease in which there is a high concentration of serum AFP.